Cargando…
PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430021/ http://dx.doi.org/10.1097/01.HS9.0000973760.86945.e6 |
_version_ | 1785090853919784960 |
---|---|
author | Ilan, Uri Boer, Judith M. Burkhardt, Birgit van Delft, Frederik Izraeli, Shai Klusmann, Jan-Henning Moerloose, Barbara De Velasco, Pablo Irving, Julie Fuster, José Luis Erdélyi, Dániel Kulozik, Andreas E Reinhardt, Dirk Zwaan, Michel den Boer, Monique L. |
author_facet | Ilan, Uri Boer, Judith M. Burkhardt, Birgit van Delft, Frederik Izraeli, Shai Klusmann, Jan-Henning Moerloose, Barbara De Velasco, Pablo Irving, Julie Fuster, José Luis Erdélyi, Dániel Kulozik, Andreas E Reinhardt, Dirk Zwaan, Michel den Boer, Monique L. |
author_sort | Ilan, Uri |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104300212023-08-17 PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107 Ilan, Uri Boer, Judith M. Burkhardt, Birgit van Delft, Frederik Izraeli, Shai Klusmann, Jan-Henning Moerloose, Barbara De Velasco, Pablo Irving, Julie Fuster, José Luis Erdélyi, Dániel Kulozik, Andreas E Reinhardt, Dirk Zwaan, Michel den Boer, Monique L. Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430021/ http://dx.doi.org/10.1097/01.HS9.0000973760.86945.e6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Ilan, Uri Boer, Judith M. Burkhardt, Birgit van Delft, Frederik Izraeli, Shai Klusmann, Jan-Henning Moerloose, Barbara De Velasco, Pablo Irving, Julie Fuster, José Luis Erdélyi, Dániel Kulozik, Andreas E Reinhardt, Dirk Zwaan, Michel den Boer, Monique L. PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107 |
title | PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107 |
title_full | PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107 |
title_fullStr | PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107 |
title_full_unstemmed | PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107 |
title_short | PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107 |
title_sort | pb1725: international leukemia target board - a platform to discuss and prioritize targeted treatment options for patients with relapsed/refractory pediatric hematological malignancies (iltb) – itcc 107 |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430021/ http://dx.doi.org/10.1097/01.HS9.0000973760.86945.e6 |
work_keys_str_mv | AT ilanuri pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT boerjudithm pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT burkhardtbirgit pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT vandelftfrederik pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT izraelishai pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT klusmannjanhenning pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT moerloosebarbarade pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT velascopablo pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT irvingjulie pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT fusterjoseluis pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT erdelyidaniel pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT kulozikandrease pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT reinhardtdirk pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT zwaanmichel pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 AT denboermoniquel pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107 |